|
|
||||||||
Articles |
1
Clinical Chemistry Service, Clinical Pathology Department, Warren Grant Magnuson Clinical Center, and
2
National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD 20892.
a Address correspondence to this author, at: National Institutes of Health, Bldg. 10, Rm. 2C-407, 10 Center Dr. MSC 1508, Bethesda, MD 20892-1508. Fax 301-402-1885; e-mail ehristova{at}nih.gov
| Abstract |
|---|
|
|
|---|
Key Words: indexing terms: ion-selective electrodes electrolytes ethanol variation, source of
| Introduction |
|---|
|
|
|---|
Since the first report in 1936 by Cline and Coleman (5), numerous studies have been published describing a marked deficiency of total magnesium (tMg) in chronic alcoholism (6)(7). Several mechanisms associated with alcoholism contribute to the magnesium deficiency, including urinary Mg wastage, malnutrition, gastrointestinal losses, phosphate deficiency, acidosis/alkalosis, vitamin D deficiency, and free fatty acidemia associated with alcohol (ethanol) withdrawal (6). The potential detrimental effects of Mg deficiency are well established. Alcoholics, who are already at risk for multiple system failure because of malnutrition and the toxic effects of alcohol on all tissues, have the potential for exaggerated risk for morbidity and mortality in the presence of Mg deficiency (7). Intracellular Mg concentration is the critical analyte in diagnosing Mg deficiency. Studies in vivo, as well as quantitative digital imaging microscopy of cultured cells, reveal that alcohol induces rapid concentration-dependent depletion of iMg (7). However, the high level of expertise required for intracellular measurements of iMg precludes the determination of this analyte in routine clinical chemistry laboratories.
To complement the preceding studies, ion-selective electrodes (ISEs) for iMg recently introduced by various manufacturers allow the direct assessment of iMg in the extracellular space (8)(9)(10)(11). Given that serum iMg is thought to be in equilibrium with the intracellular compartment (12), determination of serum iMg may have clinical value in assessing disorders of Mg metabolism.
The aim of this investigation was to study serum iMg concentrations (determined with two different ion-selective analyzers) in subjects with chronic alcoholism; the relation of serum iMg to serum tMg in these subjects; and any possible changes in these analytes after a period of abstinence. Our previous experience with the ISEs used here indicated some unexplained discrepancies in results for iMg in healthy subjects and in a group of randomly selected patients (10). In this study, therefore, we also examined the effect of ethanol, ß-hydroxybutyrate, and acetoacetate on the Mg ISEs and performed routine biochemical determinations in an effort to relate potential between-analyzer differences in iMg to the biochemical profile in the subjects investigated.
| Materials and Methods |
|---|
|
|
|---|
All participants were volunteers under no legal constraints, and all gave a written informed consent before the study. All procedures were in accordance with the ethical standards laid down in the Helsinki Declaration of 1975, as revised in 1983.
Specimen collection and biochemical determinations.
Initial blood specimens for routine biochemical determinations were
drawn from all of the patients at the time of admission, before the
administration of any medication. Using general clinical chemistry
analyzers, we analyzed the samples for glucose, albumin, total protein,
aspartate aminotransferase, alanine aminotransferase,
-glutamyltransferase, alkaline phosphatase, total bilirubin, blood
urea nitrogen, creatinine, uric acid, electrolytes, tMg, total and
ionized calcium, phosphorus, lactate, hemoglobin, and prothrombin time.
The specimens for iMg, obtained within 48 h of the time of
admission, were analyzed by ISEs on two different instruments: NOVA CRT
(NOVA Biomedical, Waltham, MA) and AVL 988-4 (AVL, Roswell, GA). The
blood was drawn without forearm exercise into Vacutainer Tubes (Becton
Dickinson, Rutherford, NJ; cat. no. 6397), under strictly anaerobic
conditions. A description of both ISE instruments and of their
analytical performance has been published previously (10).
We obtained additional samples for tMg and iMg determinations from 13 of the alcoholic patients who participated in standard inpatient detoxification treatment, after 3 weeks of abstinence. Again, their initial blood measurements were conducted before any medication had been administered.
Effect of ethanol and keto acids on the iMg electrodes.
Because iMg determination in alcoholic subjects may involve assay of
samples taken while the subjects are intoxicated or having metabolic
disturbances (most commonly, metabolic acidosis), we studied the
potential interference of ethanol, ß-hydroxybutyrate, and
acetoacetate on the performance of the two iMg electrodes used in the
study. To test the effect of ethanol, we first prepared a series of
working solutions at three different concentrations of Mg by adding
MgCl2 · 6H20 to AVL Standard A (0.30,
0.98, and 1.65 mmol/L) and to NOVA Set C Level 1 (0.35, 1.02, and 1.68
mmol/L) calibrator solutions and then added increasing concentrations
of ethanol (1.0, 2.0,and 4.0 g/L) to each solution. Similarly, for the
other two potential interferents tested, we added increasing
concentrations of ß-hydroxybutyrate (2.0, 6.0, and 10 mg/L) or
acetoacetate (1.0, 2.0, and 5.0 mg/L) to the NOVA and AVL calibrator
solutions, which had been supplemented to contain tMg at 1 mmol/L.
All specimens were analyzed in triplicate on NOVA CRT and AVL 988-4 analyzers. Clinical significance was judged relevant if the difference in the results before and after addition of the interferent exceeded 10% of the iMg concentration in the working solutions.
Data and statistical analyses.
We expressed results as
mean ± SE and analyzed within- and between-group comparisons by
using Student's t-test and Deming (debiased) regression, as
appropriate. Correlations were assessed with simple and multiple
stepwise linear regression. All analyses were two-tailed and conducted
with SAS software (Version 6.08 for Windows; SAS Institute, Cary, NC)
and Microsoft Excel (Version 4.0; Microsoft, Redmond, WA). P
<0.05 was considered statistically significant.
| Results |
|---|
|
|
|---|
-glutamyltransferase, alkaline phosphatase, anion
gap, and chloride; and P <0.03 for hemoglobin, total
bilirubin, total protein, glucose, blood urea nitrogen, uric acid, and
sodium.
iMg and tMg differences between chronic alcoholics and
controls.
The results for tMg, iMg, and %iMg in chronic
alcoholics and controls are summarized in Table 1
. Fig. 1
shows the distribution of iMg in both groups, as measured with
a NOVA CRT and an AVL 988-4. All of the controls had tMg values within
the reference interval, 0.651.05 mmol/L; for 13% of the alcoholics,
however, tMg was <0.65 mmol/L.
|
|
For iMg, 42% (n = 13) of the alcoholics had a NOVA result of <0.39 mmol/L, but none had NOVA iMg >0.64 mmol/L (iMg reference interval on the NOVA CRT, 0.390.64 mmol/L) (10). In contrast, only 6.5% (n = 2) of the AVL iMg results for the alcoholics were <0.44 mmol/L, whereas 19% (n = 6) exceeded 0.60 mmol/L (AVL reference interval, 0.440.60 mmol/L) (10). None of the controls had iMg below the reference interval on either instrument, although 3 (7.5%) had an AVL iMg value >0.60 mmol/L. The lowest serum iMg concentration detected in an alcoholic was 0.13 mmol/L by the NOVA and 0.41 mmol/L by the AVL. For the controls, these values were 0.42 and 0.45 mmol/L, respectively.
There was a significant difference between the alcoholics and controls
for tMg (P <0.001) and for the NOVA iMg (P
<0.001) results but not for the AVL iMg results (P >0.05).
The alcoholics had lower %iMg (i.e., iMg/tMg) calculated from the NOVA
iMg results (P <0.001), but percentages were similar to
those in the controls when calculated from the AVL iMg (P
>0.05) (Table 1
). The nine alcoholics who did not consume alcohol for
several months had tMg of 0.86 ± 0.01 mmol/L and iMg (by AVL) of
0.58 ± 0.008 mmol/L, not significantly different from the values
for the control group (P >0.05). The mean NOVA iMg for this
group, however, was 0.38 ± 0.01 mmol/Lwhich was statistically
different from the iMg in the control group (P <0.001).
Effect of abstinence on tMg and iMg.
After 3 weeks of
abstinence, the serum concentrations of tMg and of iMg (by both NOVA
and AVL) increased significantly (Table 1
). Furthermore, mean tMg (0.85
mmol/L) and mean iMg by AVL (0.58 mmol/L) in these subjects were
similar to the mean values in the controls (0.85 and 0.56 mmol/L,
respectively). The mean NOVA iMg (0.41 mmol/L), however, was still well
below the mean value for the control group (0.50 mmol/L). The increase
in tMg and iMg serum concentrations was accompanied by normalization of
the values for the liver enzymes.
Analyzer-dependent differences for iMg.
The
difference in mean iMg values between the two instruments was
statistically significant in both alcoholics (paired t-test,
P <0.001) and controls (P <0.001) (Table 1
,
Fig. 2
). In the control group, the Deming (debiased) regression showed
an acceptable slope of 1.007, an intercept of 0.057 mmol/L, and
Sy|x = 0.01 mmol/L. The low
correlation coefficient (r = 0.272) was attributed to
the narrow iMg range among those subjects. The alcoholic group,
however, had a slope of -0.382, an intercept of 0.676 mmol/L, and
Sy|x
= 0.02 mmol/L. When we compared only values for the alcoholics with iMg
0.38 mmol/L by NOVA (n = 13), the mean between-analyzer
difference for iMg was 0.23 mmol/L. For comparison, the mean difference
between the alcoholics for whom iMg was >0.39 mmol/L by NOVA was 0.09
mmol/L (n = 18); for the control group, that difference was only
0.06 mmol/L.
|
Correlation.
The correlation between serum tMg and the
AVL iMg was significant and positive in both alcoholics
(r = 0.864, P <0.001) and controls
(r = 0.740, P <0.001). However, NOVA iMg
results were significantly and positively correlated to tMg only in the
control group (r = 0.389, P <0.03), not in
the alcoholic group (r = -0.058, P >0.7)
(Fig. 3
). Application of stepwise linear multiple regression analysis
to evaluate the relation between the serum iMg and each of the
followingtMg, total and ionized calcium, albumin, total protein,
electrolytes, phosphorus, and anion gapgave the best fit for the
relation between iMg and tMg. Because addition of these other variables
did not improve the fit, we concluded that they did not have an
independent effect on iMg differences between instruments and between
groups.
|
Analytical interference of ethanol and keto acids.
Our
interference study with ethanol, ß-hydroxybutyrate, and acetoacetate
did not detect any clinically significant changes (differences
exceeding ±10%) in the iMg results measured by either ISE instrument.
| Discussion |
|---|
|
|
|---|
We suggest two possible explanations for the observed discrepancy: First, most of the NOVA iMg results for alcoholics were at or below the instrument's lower reference limit of 0.39 mmol/L, the area in which the NOVA and AVL disagreed the most (mean difference 0.23 mmol/L). Several methodological factors such as differences in the manufacturers' calibration solutions, reference electrode construction, and the liquid-junction potential have been associated with this lack of agreement and have already been described (10)(15). Second, potential interferents in the alcoholics' specimens would have to affect the analytical performance of the iMg electrodes or at least the performance of the ion-selective membrane. The results from our interference study and other recently published data (14) lead us to conclude that ethanoland ß-hydroxybutyrate and acetoacetateare unlikely to affect the ISE measurements of iMg.
In a previous study, Rehak et al. (15) found that the responses of both AVL and NOVA ISEs for iMg were affected by an increase in the measured concentration of ionized calcium. The mean ionized calcium in our alcoholic group, however, as measured on either instrument, did not differ significantly from that in the controls [NOVA: 1.21 vs 1.19 mmol/L, respectively (P >0.05); AVL: 1.28 vs 1.25 mmol/L, respectively (P >0.05)]. Even after analysis of a possible relation between the difference in the iMg results and the unique biochemical profile of the alcoholics, we were not able to verify that any of the tested analytes had affected the performance of the instruments. In our opinion, therefore, the difference in the results between the two analyzers is primarily attributable to differences in the design, construction, and calibration of these two ISEs.
A low tMg is expected in subjects with chronic alcoholism (6)(7). The mean tMg of 0.78 mmol/L in our alcoholics is a little higher than but in agreement with the results reported by De Marchi et al. (16), 0.70 ± 0.15 mmol/L (n = 61). Among the factors likely to contribute to our higher results could be differences in the proportion of alcoholics studied with tMg <0.65 mmol/L (13% in our study vs 30% reported by De Marchi et al.), methodological differences for tMg determinations, and sample selection bias (0.85 mmol/L mean tMg in our control group vs 0.90 mmol/L in theirs).
Recently published data by Wu and Kenny (14) showed that acute alcohol consumption is more likely to influence serum iMg than tMg. Mean iMg was 0.349 mmol/L in their ethanol-positive specimenssignificantly below normal and not correlated with the mean tMg, which was 0.865 mmol/L and not significantly different from the tMg in their controls. In our alcoholic group, the iMg measured by the NOVA also did not correlate significantly with the tMg (r = 0.058, P >0.05); however, our group of chronic alcoholics had years of excessive alcohol consumption and, unlike the ethanol-positive group studied by Wu and Kenny, also had decreased tMg.
The correlation between the tMg and NOVA iMg was positive and
significant in our controls, as was the correlation between tMg and AVL
iMg in both controls and alcoholics. Further, an increase in the serum
tMg in our group of alcoholics was associated with a decrease in %iMg
measured with the NOVA (Fig. 3
). The negative slope (-0.051) was
mainly attributable to the results for three alcoholics who had both
very low NOVA iMg values (0.13, 0.16, and 0.24 mmol/L) and normal tMg
(0.82, 0.91, and 0.93 mmol/L, respectively). Excluding these three
results from the analysis gave a correlation between tMg and NOVA iMg
in the alcoholics that was close to that found for the control group
(slope 0.206, intercept 0.247 mmol/L, r = 0.344). After
examining the hospital records of the three alcoholics, however, we
could find no clinical reasons to exclude their results from the study.
After 3 weeks of abstinence, the concentrations of tMg and iMg in the alcoholics (n = 13) increased. Only tMg and AVL iMg values, however, reached the mean concentrations of the control group. Recent publications have indicated that acute alcohol consumption is associated with some electrolyte and metabolite disturbances, which tend to normalize after even a short period of abstinence (16). In support of this observation are our results for the nine alcoholics who were abstinent at the time of admission. Their tMg and AVL iMg concentrations did not differ significantly from those of the controls (P >0.05); their NOVA iMg (0.37 mmol/L), however, was almost identical with the mean iMg in those alcoholics who had been drinking until the time of admission (0.38 mmol/L).
In conclusion, this and earlier studies show that determination of iMg activity in biological fluids is influenced by several factors and that the values found for it may differ somewhat when measured with different instruments. In particular, the status of serum iMg in alcoholics cannot be assessed with the necessary degree of certainty by current ISE methodologies; accordingly, the usefulness of iMg determinations is yet to be established.
| Footnotes |
|---|
1 Nonstandard abbreviations: tMg, total Mg; iMg, ionized Mg; and ISE, ion-selective electrode. ![]()
| References |
|---|
|
|
|---|
The following articles in journals at HighWire Press have cited this article:
![]() |
N. N. Rehak, S. A. Cecco, J. E. Niemela, and R. J. Elin Thiocyanate in smokers interferes with the Nova magnesium ion-selective electrode Clin. Chem., September 1, 1997; 43(9): 1595 - 1600. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |